160 161 162 163 164 165 166 167 168 169 170 171 [172] 173 174 175 176 177 178 179 180 
| PRODUCT NAME | CAS Registry Number | ||||||||
| ERITADENINE,IH (0 suppliers) | |||||||||
| Erithromycin Base (1 supplier) | |||||||||
| Erithromycin Estolate (1 supplier) | |||||||||
| ERITHROTONE (1 supplier) | 185918-15-4 | ||||||||
ERITORAN (7 suppliers)
IUPAC Name: [(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] dihydrogen phosphate | CAS Registry Number: 185955-34-4Synonyms: Eritoran [INN], CHEBI:614906, CID6912404, CID 6912404, {[(2R,3R,4R,5S,6R)-4-(decyloxy)-5-hydroxy-6-({[(2R,3R,4R,5S,6R)-4-{[(3R)-3-methoxydecyl]oxy}-6-(methoxymethyl)-3-[(11Z)-octadec-11-enamido]-5-(phosphonooxy)oxan-2-yl]oxy}methyl)-3-(3-oxotetradecanamido)oxan-2-yl]oxy}phosphonic acid, na
InChIKey: BPSMYQFMCXXNPC-MFCPCZTFSA-N | 185955-34-4 | ||||||||
Eritoran Tetrasodium (3 suppliers)
IUPAC Name: tetrasodium;[(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonatooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] phosphate | CAS Registry Number: 185954-98-7Synonyms: Eritoran tetrasodium, E5564, ERITORAN, alpha-D-Glucopyranose, 3-O-decyl-2-deoxy-6-O-(2-deoxy-3-O-((3R)-3-methoxydecyl)-6-O-methyl-2-(((11Z)-1-oxo-11-octadecenyl)amino)-4-O-phosphono-beta-D-glucopyranosyl)-2-((1,3-dioxotetradecyl)amino)-,1-(dihydrogen phosphate), tetrasodium salt, UNII-FUO195TC7O, Eritoran tetrasodium (USAN), AC1O516M, CHEBI:46692, DB04933, LS-185891, D04043, E-5564, 3-O-Decyl-2-deoxy-6-O-(2-deoxy-3-O-((3R)-3-methoxydecyl)-6-O-methyl-2-((11Z)-octadec-11-enoylamino)-4-O-phosphonato-beta-D-glucopyranosyl)-2-((3-oxotetradecanoyl)amino)-alpha-D-glucopyranosyl tetrasodium phosphate, alpha-D-Glucopyranose, 3-O-decyl-2-deoxy-6-O-(2-deoxy-3-O-((3R)-3-methoxydecyl)-6-O-methyl-2-(((11Z)-1-oxo-11-octadecenyl)amino)-4-O-phosphono-beta-D-glucopyranosyl)-2-((1,3-dioxotetradecyl)amino)-, 1-(dihydrogen phosphate), tetrasodium salt, tetrasodium [(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonatooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] phosphate, tetrasodium 3-O-decyl-2-deoxy-6-O-{2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[(11Z)-octadec-11-enoylamino]-4-O-phosphonato-beta-D-glucopyranosyl}-2-[(3-oxotetradecanoyl)amino]-1-O-phosphonato-alpha-D-glucopyranose
InChIKey: FEMINZOAAWPBPP-RHMAUSBNSA-J | 185954-98-7 | ||||||||
| ERIZEPINE (3 suppliers) | 96645-87-3 | ||||||||
ERIZOMYCIN (5 suppliers)
IUPAC Name: N-[2-butan-2-ylidene-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododec-6-yl]-3-hydroxypyridine-2-carboxamide | CAS Registry Number: 18791-21-4Synonyms: Pyridomycin, CID317012, NSC246134, NCI60_001971, 2-Pyridinecarboxamide, 3-hydroxy-N-[10-hydroxy-5,11-dimethyl-2-(1-methylpropylidene)-3,7,12-trioxo-9-(3-pyridinylmethyl)-1,4-dioxa-8-azacyclododec-6-yl]-, [5R-(2Z,5R*,6S*,9S*,10S*,11R*)]-
InChIKey: WHIKSLGSXKIHCA-UHFFFAOYSA-N | 18791-21-4 | ||||||||
| ERK 1/2 /MAP KINASE SUBSTRATE, FAM LABELED (0 suppliers) | |||||||||
| ERK 1/2 /MAP KINASE SUBSTRATE, FAM LABELED  (0 suppliers) | |||||||||
| ERK ANTIBODY (0 suppliers) | |||||||||
ERK INHIBITOR (8 suppliers)
IUPAC Name: 3-(2-aminoethyl)-5-[(4-ethoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione;hydrochloride | CAS Registry Number: 1049738-54-6Synonyms: SCHEMBL15021964, CTK8F9482, HE190731, 3-(2-AMINOETHYL)-5-((4-ETHOXYPHENYL)METHYLENE)-2,4-THIAZOLIDINEDIONE HCL, 3-(2-Aminoethyl)-5-((4-ethoxyphenyl)methylene)-2,4-thiazolidinedione hydrochloride, powder, >=98% (HPLC)
InChIKey: PQVLWVGMXJPJLG-UHFFFAOYSA-N | 1049738-54-6 | ||||||||
ERK Inhibitor II, Negative Control (5 suppliers)
IUPAC Name: 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1,2-dihydropyrazolo[3,4-c]pyridazin-3-one | CAS Registry Number: 1177970-73-8Synonyms: 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ol, CHEMBL2218938, CTK8F0254, HMS3229G08, CCG-206838
InChIKey: QMBDONCHHMIWFJ-UHFFFAOYSA-N | 1177970-73-8 | ||||||||
| ERK Inhibitor III (1 supplier) | |||||||||
| ERK SUBSTRATE (LABELED WITH FLUORESEIN) (0 suppliers) | |||||||||
| ERK(EXTRACELLULAR SIGNAL-REGULATED KINASE), CERTIFIED REFERENCE MATERIAL (0 suppliers) | |||||||||
| ERK-1 ANTIBODY (1E5) (0 suppliers) | |||||||||
| ERK-CLIPTAC (1 supplier) | 2087490-46-6 | ||||||||
| ERK-IN-2 (1 supplier) | |||||||||
| ERK-IN-2 (free base) (1 supplier) | 2743576-55-6 | ||||||||
ERK-IN-3 (7 suppliers)
IUPAC Name: N-[(1S)-2-amino-1-(3-chloro-5-fluorophenyl)ethyl]-1-[5-methyl-2-(oxan-4-ylamino)pyrimidin-4-yl]imidazole-4-carboxamide | CAS Registry Number: 2055597-12-9Synonyms: ASN007, ASN007 free base, Asn007 rd, CHEMBL4650280, SCHEMBL18298340, ASN-007, NSC828319, NSC-828319, HY-136579, CS-0131841, N-[(1S)-2-amino-1-(3-chloro-5-fluorophenyl)ethyl]-1-[5-methyl-2-(oxan-4-ylamino)pyrimidin-4-yl]imidazole-4-carboxamide
InChIKey: PWHIUQBBGPGFFV-GOSISDBHSA-N | 2055597-12-9 | ||||||||
| ERK-IN-3 (benzenesulfonate) (3 suppliers) | 2055597-39-0 | ||||||||
| ERK-IN-7 (0 suppliers) | 2494010-63-6 | ||||||||
| ERK-IN-8 (0 suppliers) | 2226293-75-8 | ||||||||
| ERK-MYD88 interaction inhibitor 1 (1 supplier) | 2215927-89-0 | ||||||||
| ERK1 (0 suppliers) | |||||||||
| ERK1 (P44, MAPK3), ACTIVE (0 suppliers) | 1915-09-25 | ||||||||
| ERK1 (P44, MAPK3), UNACTIVE (0 suppliers) | |||||||||
| ERK1 , ACTIVE (0 suppliers) | |||||||||
| ERK1 , INACTIVE (0 suppliers) | |||||||||
| ERK1/2 (PAIRED202/204) (0 suppliers) | |||||||||
| ERK1/2 (PT202/PY204) (0 suppliers) | |||||||||
ERK1/2 inhibitor 1 (4 suppliers)
IUPAC Name: (2R)-2-[5-[5-chloro-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxo-1H-isoindol-2-yl]-N-[(1S)-2-hydroxy-1-(3-methylphenyl)ethyl]propanamide | CAS Registry Number: 2095719-90-5Synonyms: CHEMBL4212211, (2R)-2-[5-[5-chloro-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxo-1H-isoindol-2-yl]-N-[(1S)-2-hydroxy-1-(3-methylphenyl)ethyl]propanamide, (2~{R})-2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]-~{N}-[(1~{S})-1-(3-methylphenyl)-2-oxidanyl-ethyl]propanamide, GTPL9973, SCHEMBL18766105, BDBM50456348, compound 27 [PMID: 29775310], HY-112287, CS-0044721, ESN
InChIKey: XHOJEECXVUMYMF-IQGLISFBSA-N | 2095719-90-5 | ||||||||
| ERK1/2 inhibitor 11 (1 supplier) | |||||||||
| ERK1/2 inhibitor 3 (2 suppliers) | 2737294-99-2 | ||||||||
| ERK1/2 inhibitor 4 (2 suppliers) | 2490396-99-9 | ||||||||
| ERK1/2 inhibitor 5 (1 supplier) | 2560552-75-0 | ||||||||
| ERK1/2 inhibitor 6 (2 suppliers) | 2634816-13-8 | ||||||||
| ERK1/2 inhibitor 7 (2 suppliers) | 2648455-13-2 | ||||||||
| ERK1/2 inhibitor 8 (1 supplier) | 2648368-43-6 | ||||||||
ERK1/2 inhibitor 9 (2 suppliers)
IUPAC Name: [(4Z)-cyclooct-4-en-1-yl] N-[4-[4-[[5-chloro-4-[2-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]pyridin-2-yl]but-3-ynyl]carbamate | CAS Registry Number: 2169302-75-2Synonyms: DA-73183, HY-153738, CS-0835900
InChIKey: MEGBFSKPEJSVCC-ARJAWSKDSA-N | 2169302-75-2 | ||||||||
| ERK2 (P42, MAPK1), ACTIVE (0 suppliers) | |||||||||
| ERK2 (P42, MAPK1), UNACTIVE (0 suppliers) | |||||||||
| ERK2 / MAPK1, ACTIVE (0 suppliers) | |||||||||
| ERK2 / MAPK1, INACTIVE (0 suppliers) | |||||||||
| ERK2 allosteric-IN-1 (1 supplier) | 872591-16-7 | ||||||||
| ERK2 ANTIBODY (0 suppliers) | |||||||||
| ERK2 ANTIBODY (4C11) (0 suppliers) | |||||||||
| ERK2 IN-1 (2 suppliers) | 1093061-47-2 | ||||||||
| ERK2 IN-5 (1 supplier) | 353250-09-6 |